Evidence map›Paper›PMID 39106493›Full record

ArticleJournal of the American Chemical Society2024

Systematic Preparation of a 66-IgG Library with Symmetric and Asymmetric Homogeneous Glycans and Their Functional Evaluation.

Shino Manabe, Shogo Iwamoto, Satoru Nagatoishi, Asako Hoshinoo, Ai Mitani, Wataru Sumiyoshi, Takashi Kinoshita, Yoshiki Yamaguchi, Kouhei Tsumoto

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shino ManabeSchool of Pharmacy and Pharmaceutical Sciences and Institute of Medicinal Chemistry, Hoshi University, Ebara, Shinagawa-ku, Tokyo 142-8501, Japan.ORCID 0000-0002-2763-1414
Shogo IwamotoFushimi Pharmaceutical Co., Ltd., Nakazu, Marugame, Kagawa 763-8605, Japan.
Satoru NagatoishiMedical Device Development and Regulation Research Center, School of Engineering, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.ORCID 0000-0002-0794-3963
Asako HoshinooFushimi Pharmaceutical Co., Ltd., Nakazu, Marugame, Kagawa 763-8605, Japan.
Ai MitaniFushimi Pharmaceutical Co., Ltd., Nakazu, Marugame, Kagawa 763-8605, Japan.
Wataru SumiyoshiFushimi Pharmaceutical Co., Ltd., Nakazu, Marugame, Kagawa 763-8605, Japan.ORCID 0000-0002-2855-4529
Takashi KinoshitaFushimi Pharmaceutical Co., Ltd., Nakazu, Marugame, Kagawa 763-8605, Japan.
Yoshiki YamaguchiInstitute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Komatsushima, Aoba-ku, Sendai, Miyagi 980-8558, Japan.ORCID 0000-0003-0100-5439
Kouhei TsumotoMedical Device Development and Regulation Research Center, School of Engineering, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.ORCID 0000-0001-7643-5164

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulin G (IgG) antibodies possess a conserved

Indexed as

Immunoglobulin GPolysaccharidesTrastuzumabAntibody-Dependent Cell CytotoxicityGlycosylationHumansImmunoglobulin GPolysaccharidesTrastuzumab

Identifiers

PMID39106493
PMCPMC11345770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.